Top

BMC Cancer

Published in:

Open Access 01-12-2021 | Research article

Salvage surgery for patients with residual/persistent diseases after improper or insufficient treatment of oral squamous cell carcinoma: can we rectify these mistakes?

Authors: Yue He, Zhonglong Liu, Surui Sheng, Weijin Gao, Xiao Tang, Xiaoguang Li, Chunyue Ma

Published in: BMC Cancer | Issue 1/2021

Abstract

Background

Patterns of failure after treatment of oral and squamous cell carcinomas (OSCC) are diversified, with recurrences being one of the common causes. A special group of patients are sometimes encountered in the outpatient clinic for improper or insufficient initial treatment with reports of positive margins, implying residual/persistent diseases. The question of whether these patients can be surgically salvaged remain unanswered.

Methods

A retrospective study was performed between January 2013 and December 2017 for patients with residual or rapid recurrent (within 3 months) OSCCs, who received salvage surgeries in our institution. The patients with residual/persistent OSCCs were those with microscopic or macroscopic positive surgical margins, while those with rapid recurrent OSCCs were those with close or negative margins, but unabated painful symptoms right after treatment. Both clinicopathological and prognostic variables were analyzed. The focus was also directed towards lessons for possible initial mistakes, resulting in these residual/persistent diseases.

Results

Of 103 patients, 68 (66%) were men, with mean age of 56.3 years. The overall survival reached 60.2%. Regarding the primary OSCC status, most of our patients (n = 75, 72.8%) were diagnosed with ycT2–3 stages. Besides, most patients were found with macroscopic residual diseases (52.4%) before our salvage surgery. The sizes of the residual/persistent OSCCs were generally under 4 cm (87.3%) with minimally residual in 21 (20.4%). Among all the variables, primary T stage (p = 0.003), and residual lesion size (p < 0.001) were significantly associated with the prognosis in multivariate analysis. Though the causes for the initial surgical failure were multifactorial, most were stemmed from poor planning and unstandardized execution.

Conclusions

Cases with residual/persistent OSCCs were mostly due to mistakes which could have been avoided under well-round treatment plans and careful surgical practice. Salvage surgery for cases with smaller residual/persistent OSCCs is still feasible with acceptable outcomes.

Available only for authorised users

Montero PH, Patel SG. Cancer of the oral cavity. Surg Oncol Clin N Am. 2015;24(3):491–508. https://doi.org/10.1016/j.soc.2015.03.006.CrossRefPubMedPubMedCentral

Weckx A, Riekert M, Grandoch A, Schick V, Zöller JE, Kreppel M. Time to recurrence and patient survival in recurrent oral squamous cell carcinoma. Oral Oncol. 2019;94:8–13. https://doi.org/10.1016/j.oraloncology.2019.05.002.CrossRefPubMed

Ettinger KS, Ganry L, Fernandes RP. Oral cavity Cancer. Oral Maxillofac Surg Clin North Am. 2019;31(1):13–29. https://doi.org/10.1016/j.coms.2018.08.002.CrossRefPubMed

Leeman JE, Li JG, Pei X, Venigalla P, Zumsteg ZS, Katsoulakis E, et al. Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques. JAMA Oncol. 2017;3(11):1487–94. https://doi.org/10.1001/jamaoncol.2017.0973.CrossRefPubMedPubMedCentral

Mannelli G, Comini LV, Piazza C. Surgical margins in oral squamous cell cancer: intraoperative evaluation and prognostic impact. Curr Opin Otolaryngol Head Neck Surg. 2019;27(2):98–103. https://doi.org/10.1097/MOO.0000000000000516.CrossRefPubMed

Lee DY, Abraham J, Ross E, Ridge JA, Lango MN, Liu JC, et al. Rapid recurrence in head and neck cancer: underappreciated problem with poor outcome. Head Neck. 2021;43(1):212–22. https://doi.org/10.1002/hed.26479.CrossRefPubMed

Kamat M, Rai BD, Puranik RS, Datar UV. A comprehensive review of surgical margin in oral squamous cell carcinoma highlighting the significance of tumor-free surgical margins. J Cancer Res Ther. 2019;15(3):449–54. https://doi.org/10.4103/jcrt.JCRT_273_17.CrossRefPubMed

Hosni A, Huang SH, Chiu K, Xu W, Su J, Bayley A, et al. Predictors of early recurrence prior to planned postoperative radiation therapy for Oral cavity squamous cell carcinoma and outcomes following salvage intensified radiation therapy. Int J Radiat Oncol Biol Phys. 2019;103(2):363–73. https://doi.org/10.1016/j.ijrobp.2018.09.013.CrossRefPubMed

Ho AS, Kraus DH, Ganly I, Lee NY, Shah JP, Morris LG. Decision making in the management of recurrent head and neck cancer. Head Neck. 2014;36(1):144–51. https://doi.org/10.1002/hed.23227.CrossRefPubMed

10.

McSpadden R, Zender C, Eskander A. AHNS series: do you know your guidelines? Guideline recommendations for recurrent and persistent head and neck cancer after primary treatment. Head Neck. 2019;41(1):7–15. https://doi.org/10.1002/hed.25443.CrossRefPubMed

11.

Steinbichler TB, Golm L, Dejaco D, Riedl D, Kofler B, Url C, et al. Surgical rescue for persistent head and neck cancer after first-line treatment. Eur Arch Otorhinolaryngol. 2020;277(5):1437–48. https://doi.org/10.1007/s00405-020-05807-0.CrossRefPubMedPubMedCentral

12.

Kain JJ, Birkeland AC, Udayakumar N, Morlandt AB, Stevens TM, Carroll WR, et al. Surgical margins in oral cavity squamous cell carcinoma: current practices and future directions. Laryngoscope. 2020;130(1):128–38. https://doi.org/10.1002/lary.27943.CrossRefPubMed

13.

Smits RWH, van Lanschot CGF, Aaboubout Y, de Ridder M, Hegt VN, Barroso EM, et al. Intraoperative assessment of the resection specimen facilitates achievement of adequate margins in oral carcinoma. Front Oncol. 2020;10:614593. https://doi.org/10.3389/fonc.2020.614593.CrossRefPubMedPubMedCentral

14.

Rohde M, Rosenberg T, Pareek M, Nankivell P, Sharma N, Mehanna H, et al. Definition of locally recurrent head and neck squamous cell carcinoma: a systematic review and proposal for the Odense–Birmingham definition. Eur Arch Otorhinolaryngol. 2020;277(6):1593–9. https://doi.org/10.1007/s00405-020-05953-5.CrossRefPubMed

15.

Pollaers K, Hinton-Bayre A, Friedland PL, Farah CS. AJCC 8th edition oral cavity squamous cell carcinoma staging - is it an improvement on the AJCC 7th edition? Oral Oncol. 2018;82:23–8. https://doi.org/10.1016/j.oraloncology.2018.04.018.CrossRefPubMed

16.

Koyfman SA, Ismaila N, Crook D, D'Cruz A, Rodriguez CP, Sher DJ, et al. Management of the Neck in squamous cell carcinoma of the Oral cavity and oropharynx: ASCO clinical practice guideline. J Clin Oncol. 2019;37(20):1753–74. https://doi.org/10.1200/JCO.18.01921.CrossRefPubMedPubMedCentral

17.

Quinlan-Davidson SR, Morrison HW, Myers JN, et al. Recurrent oral cavity cancer: patterns of failure after salvage multimodality therapy. Head Neck. 2017;39(4):633–8. https://doi.org/10.1002/hed.24666.CrossRefPubMed

18.

Tasche KK, Buchakjian MR, Pagedar NA, Sperry SM. Definition of “close margin” in Oral Cancer surgery and Association of Margin Distance with Local Recurrence Rate. JAMA Otolaryngol Head Neck Surg. 2017;143(12):1166–72. https://doi.org/10.1001/jamaoto.2017.0548.CrossRefPubMedPubMedCentral

19.

Hamoir M, Schmitz S, Suarez C, Strojan P, Hutcheson K, Rodrigo J, et al. The current role of salvage surgery in recurrent head and neck squamous cell carcinoma. Cancers. 2018;10(8):267. https://doi.org/10.3390/cancers10080267.CrossRefPubMedCentral

20.

Chung EJ, Park MW, Kwon KH, Rho YS. Clinical outcomes and prognostic factor analysis after salvage surgery for recurrent squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg. 2020;49(3):285–91. https://doi.org/10.1016/j.ijom.2019.03.967.CrossRefPubMed

21.

Pfister DG, Spencer S, Adelstein D, et al. Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(7):873–98.

22.

Ojeda D, Huber MA, Kerr AR. Oral potentially malignant disorders and oral cavity cancer. Dermatol Clin. 2020;38(4):507–21. https://doi.org/10.1016/j.det.2020.05.011.CrossRefPubMed

23.

Gigliotti J, Madathil S, Makhoul N. Delays in oral cavity cancer. Int J Oral Maxillofac Surg. 2019;48(9):1131–7. https://doi.org/10.1016/j.ijom.2019.02.015.CrossRefPubMed

24.

Abati S, Bramati C, Bondi S, Lissoni A, Trimarchi M. Oral cancer and precancer: a narrative review on the relevance of early diagnosis. Int J Environ Res Public Health. 2020;17(24):9160. https://doi.org/10.3390/ijerph17249160.CrossRefPubMedCentral

25.

Fujiwara RJ, Judson BL, Yarbrough WG, Husain Z, Mehra S. Treatment delays in oral cavity squamous cell carcinoma and association with survival. Head Neck. 2017;39(4):639–46. https://doi.org/10.1002/hed.24608.CrossRefPubMed

26.

Cervico G, Fiorillo L, Herford AS, et al. Molecular biomarkers related to oral carcinomas: clinical trial outcome evaluation in a literature review. Dis Markers. 2019;2019:8040361.

27.

Lee LT, Wong YK, Hsiao HY, Wang YW, Chan MY, Chang KW. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2018;47(6):699–707. https://doi.org/10.1016/j.ijom.2017.09.016.CrossRefPubMed

28.

Qiao B, Huang J, Mei Z, Lam AK, Zhao J, Ying L. Analysis of immune microenvironment by multiplex immunohistochemistry staining in different oral diseases and oral squamous cell carcinoma. Front Oncol. 2020;10:555757. https://doi.org/10.3389/fonc.2020.555757.CrossRefPubMedPubMedCentral

29.

Cicciù M, Cervino G, Fiorillo L, D’Amico C, Oteri G, Troiano G, et al. Early diagnosis on Oral and potentially Oral malignant lesions: a systematic review on the VELscope ® fluorescence method. Dent J. 2019;7(3):93. https://doi.org/10.3390/dj7030093.CrossRef

30.

Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope. 2000;110(3 Pt 2 Suppl 93):1–18.CrossRef

31.

Zengaa J, Grossb J, Fowlerc S, et al. Salvage of recurrence after surgery and adjuvant therapy: a systematic review. Am J Otolaryngol. 2018;39:223.CrossRef

32.

Hamoir M, Holvoet E, Ambroise J, Lengelé B, Schmitz S. Salvage surgery in recurrent head and neck squamous cell carcinoma: oncologic outcome and predictors of disease free survival. Oral Oncol. 2017;67:1–9. https://doi.org/10.1016/j.oraloncology.2017.01.008.CrossRefPubMed

33.

Caldeira PC, Soto AML, de Aguiar MCF, Martins CC. Tumor depth of invasion and prognosis of early-stage oral squamous cell carcinoma: a meta-analysis. Oral Dis. 2020;26(7):1357–65. https://doi.org/10.1111/odi.13194.CrossRefPubMed

34.

Wunschel M, Neumeier M, Utpatel K, Reichert TE, Ettl T, Spanier G. Staging more important than grading? Evaluation of malignancy grading, depth of invasion, and resection margins in oral squamous cell carcinoma. Clin Oral Investig. 2021;25(3):1169–82. https://doi.org/10.1007/s00784-020-03421-2.CrossRefPubMed

35.

Wang HC, Zheng Y, Pang P, Li RW, Qi ZZ, Sun CF. Discontinuous versus in-continuity neck dissection in squamous cell carcinoma of the tongue and floor of the mouth: comparing the rates of locoregional recurrence. J Oral Maxillofac Surg. 2018;76(5):1123–32. https://doi.org/10.1016/j.joms.2017.11.021.CrossRefPubMed

36.

Piazza C, Grammatica A, Montalto N, Paderno A, Del Bon F, Nicolai P. Compartmental surgery for oral tongue and floor of the mouth cancer: oncologic outcomes. Head Neck. 2019;41(1):110–5. https://doi.org/10.1002/hed.25480.CrossRefPubMed

37.

Ando M, Asai M, Asakage T, Oyama W, Saikawa M, Yamazaki M, et al. Metastatic neck disease beyond the limits of a neck dissection: attention to the 'para-hyoid' area in T1/2 oral tongue cancer. Jpn J Clin Oncol. 2009;39(4):231–6. https://doi.org/10.1093/jjco/hyp001.CrossRefPubMed

38.

Suresh S, Thomas S, Janardhan D, Patil S, George NA, Varghese BT, et al. 'Doing as little as possible and as much as necessary' - oncological efficacy of marginal mandibulectomy in resection of oral cavity cancers. Oral Oncol. 2019;95:91–4. https://doi.org/10.1016/j.oraloncology.2019.05.026.CrossRefPubMed

39.

Kerker FA, Adler W, Brunner K, Moest T, Wurm MC, Nkenke E, et al. Anatomical locations in the oral cavity where surgical resections of oral squamous cell carcinomas are associated with a close or positive margin-a retrospective study. Clin Oral Investig. 2018;22(4):1625–30. https://doi.org/10.1007/s00784-018-2424-z.CrossRefPubMed

40.

Chone C, Silva AR, Crespo AN, Schlupp WR. Regional tumor recurrence after supraomohyoid neck dissection. Arch Otolaryngol Head Neck Surg. 2003;129(1):54–8. https://doi.org/10.1001/archotol.129.1.54.CrossRefPubMed

41.

Kim J, Kim S, Albergotti WG, Choi PA, Kaplan DJ, Abberbock S, et al. Selection of ideal candidates for surgical salvage of head and neck squamous cell carcinoma: effect of the Charlson-age comorbidity index and oncologic characteristics on 1-year survival and hospital course. JAMA Otolaryngol Head Neck Surg. 2015;141(12):1059–65. https://doi.org/10.1001/jamaoto.2015.2158.CrossRefPubMedPubMedCentral

42.

Lin CC, Lin HC. Effects of surgeon and hospital volume on 5-year survival rates following oral cancer resections: the experience of an Asian country. Surgery. 2008;143(3):343–51. https://doi.org/10.1016/j.surg.2007.09.033.CrossRefPubMed

43.

Nocon CC, Ajmani GS, Bhayani MK. Association of facility volume with positive margin rate in the surgical treatment of head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2018;144(12):1090–7. https://doi.org/10.1001/jamaoto.2018.2421.CrossRefPubMedPubMedCentral

44.

Lee CC, Ho HC, Chou P. Multivariate analyses to assess the effect of surgeon volume on survival rate in oral cancer: a nationwide population-based study in Taiwan. Oral Oncol. 2010;46(4):271–5. https://doi.org/10.1016/j.oraloncology.2010.01.006.CrossRefPubMed

45.

Eskander A, Merdad M, Irish JC, Hall SF, Groome PA, Freeman JL, et al. Volume-outcome associations in head and neck cancer treatment: a systematic review and meta-analysis. Head Neck. 2014;36(12):1820–34. https://doi.org/10.1002/hed.23498.CrossRefPubMed

46.

Su WW, Lee YH, Yen AM, et al. Impact of treatment delay on survival of oral/oropharyngeal cancers: results of a nationwide screening program. Head Neck. 2021;43(2):473–84. https://doi.org/10.1002/hed.26504.CrossRefPubMed

47.

Gleich LL, Ryzenman J, Gluckman JL, Wilson KM, Barrett WL, Redmond KP. Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible? Arch Otolaryngol Head Neck Surg. 2004;130(1):35–8. https://doi.org/10.1001/archotol.130.1.35.CrossRefPubMed

48.

Lok BH, Chin C, Riaz N, et al. Irradiation for locoregionally recurrent, never-irradiated oral cavity cancers. Clin Otolaryngol. 2019;44(2):131–7.CrossRef

49.

Tam S, Araslanova R, Low TH, et al. Estimating survival after salvage surgery for recurrent Oral cavity Cancer. JAMA Otolaryngol Head Neck Surg. 2017;143(7):685–90. https://doi.org/10.1001/jamaoto.2017.0001.CrossRefPubMedPubMedCentral

Title: Salvage surgery for patients with residual/persistent diseases after improper or insufficient treatment of oral squamous cell carcinoma: can we rectify these mistakes?
Authors: Yue He
Zhonglong Liu
Surui Sheng
Weijin Gao
Xiao Tang
Xiaoguang Li
Chunyue Ma
Publication date: 01-12-2021
Publisher: BioMed Central
Published in: BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-021-08600-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Expression and clinical implications of basic leucine zipper ATF-like transcription factor 2 in breast cancer

Robust expression of LINE-1 retrotransposon encoded proteins in oral squamous cell carcinoma

Breast lesions excised via vacuum-assisted system: could we get any clues for B3 lesions before excision biopsy?

The lipid-lowering drug fenofibrate combined with si-HOTAIR can effectively inhibit the proliferation of gliomas

Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits

Effectiveness of self-help workbook intervention on quality of life in cancer patients receiving chemotherapy: results of a randomized controlled trial

Keynote webinar | Spotlight on antibody–drug conjugates in cancer